The question of when a COVID-19 vaccine might be available is perhaps the most pressing in the world. There have been a number of recent headlines on this front, including early but encouraging results from trials. And on Wednesday, the Trump administration awarded a contract to Pfizer and a German biotech firm to potentially deliver […]
New COVID-19 model shows why early action matters
A newly released analysis of coronavirus’ spread in the U.S. suggests a haunting hypothetical: that if social distancing and stay-at-home orders had been implemented only a week earlier, more than 30,000 lives might have been saved. But that alternate scenario relies upon computer-based modeling that has its limitations. PBS NewsHour science correspondent Miles O’Brien joins […]
What computer-based models can tell us about coronavirus — and what they can’t
For months, scientists and public officials have relied upon computer-based models to try to predict the trajectory or the coronavirus outbreak. But models are not crystal balls, and all of them involve human assumptions. PBS NewsHour science correspondent Miles O’Brien reports on how the efforts that go into making these models — and their ultimate […]
Why antibody tests, a crucial step toward overcoming COVID-19, are still unreliable
Testing, both for active cases of COVID-19 and for antibodies indicating prior exposure to the disease, will be critical to resuming economic activity. In addition, scientists are racing to develop therapies for people who do get infected — especially those who become seriously ill. PBS NewsHour science correspondent Miles O’Brien joins Judy Woodruff to discuss […]
- 1
- 2
- 3
- …
- 21
- Next Page »